Hawkins James B's Form 4 filing
Iradimed Corp (IRMD) · filed Dec 9, 2021
- Accession no.
- 0000898432-21-000772
- Filed
- Dec 9, 2021
- Trade date
- Dec 7-8, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 4 derivative transactions. Open-market sales total $909.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hawkins James BCIK 0000898243 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 7, 2021 | Common Stock | AGrant or awardAcquired | +18,743 | $1.48F1 | +$27,739.64 | 36,011 | Direct | |
| Dec 7, 2021 | Common Stock | SSaleDisposed | −18,743 | $47.07F2 | −$882,233.01 | 17,268 | Direct | |
| Dec 7, 2021 | Common Stock | MOption exerciseAcquired | +4,222 | –F3 | – | 21,490 | Direct | |
| Dec 8, 2021 | Common Stock | AGrant or awardAcquired | +559 | $1.48F1 | +$827.32 | 22,049 | Direct | |
| Dec 8, 2021 | Common Stock | SSaleDisposed | −559 | $48.50 | −$27,111.5 | 21,490 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 7, 2021 | Common Stock | MOption exerciseDisposed | −18,743 | $0.00 | $0 | 10,000 | Direct | |
| Dec 7, 2021 | Common Stock | MOption exerciseDisposed | −4,222 | $0.00 | $0 | 2,037 | Direct | |
| Dec 7, 2021 | Common Stock | AGrant or awardAcquired | +2,071 | $0.00 | $0 | 2,071 | Direct | |
| Dec 8, 2021 | Common Stock | MOption exerciseDisposed | −559 | $0.00 | $0 | 9,441 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date.
Referenced by the price of 2 transactions in Table I.
- F2
This transaction was executed in multiple trades at prices ranging from $46.30 to $48.54. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2020 and 2021. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
Referenced by the price of 1 transaction in Table I.